Sex-Related Differences in Metastatic Melanoma Patients Treated with Immune Checkpoint Inhibition

SIMPLE SUMMARY: Immune checkpoint inhibitors, ICI, have revolutionized the treatment of advanced melanoma. However, given the small number of patients responding to immunotherapy and the high risk for immune-related adverse events, there has been a rising interest in recent publications to identify...

Descripción completa

Detalles Bibliográficos
Autores principales: Kudura, Ken, Basler, Lucas, Nussbaumer, Lukas, Foerster, Robert
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9600302/
https://www.ncbi.nlm.nih.gov/pubmed/36291928
http://dx.doi.org/10.3390/cancers14205145

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9600302/
https://www.ncbi.nlm.nih.gov/pubmed/36291928
http://dx.doi.org/10.3390/cancers14205145

Ejemplares similares